To see the effect of Shirodhara and Shiroabhyanga in the treatment of Hypertension

â??A clinical study to evaluate the efficacy of Takra Shirodhara along with Ksheer Bala Tail Shiro Abhyanga in the management of Raktagata Vata (Essential Hypertention)â??

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047939

Enrollment

Registered

2022-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient With Cardinal Symptoms Of Hypertension. 2. Patient Previously Diagnosed With Hypertension, Systolic Blood Pressure Between 140-160 Mm Of Hg (Grade 1) Within 5year Prior To Start The Trial. 3. Patient Willing To Sign The Consent Form.

Exclusion criteria

Exclusion criteria: 1. Patients With Age Below 35 Years And Above 70year. 2. Patient Having Secondary Hypertension. 3. Patient With Malignant Hypertension I.E. Blood Pressure Above 200/140mm Of Hg. 4. Having Any Other Serious Illness Like Coronary Artery Disease, Cerebrovascular Disease, Renal Function Impairment.

Design outcomes

Primary

Measure	Time frame
Subjective Criteria Severity Scoring Of Shiroshool (Headache) Bhrama (Giddiness) Klama(Fatigue) Hritspandan(Palpitation) Swedadhikyata(Excessive Sweating) Anidra(Insomnia) Objective Criteria Sphygmomanometer Timepoint: 45 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Pooja Kumari Dhakar

UPGIAS&R DSRRAU

atreyagyan@gmail.com9829798701

Outcome results